Skip to main content
Have a personal or library account? Click to login
Changes of Spleen in Wistar Rats Exposed to Therapeutic Doses of Dexamethasone and Medroxyprogesterone Acetate Evaluated by Stereological Parameters Cover

Changes of Spleen in Wistar Rats Exposed to Therapeutic Doses of Dexamethasone and Medroxyprogesterone Acetate Evaluated by Stereological Parameters

PRILOZI
Volume 36 (2015): Issue 3 (December 2015)
By: ,   and    
Open Access
|Apr 2016
References

References

  1. 1. Chung HT, Samlowski WE, Daynes RA. Modification of the murine immune system by glucocorticoids: alterations of the tissue localization properties of circulating lymphocytes. Cellular immunology. 1986; 101: 571-585.
    Open DOISearch in Google Scholar
  2. 2. Van Vliet E, Melis M, van Evijk W. The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: a flowcytometric and immunohistological analysis. Cellular Immunology. 1986; 103: 229-240.
    Open DOISearch in Google Scholar
  3. 3. Wyllie AH, Morris RG. Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol. 1982; 109: 78-87.
    Search in Google Scholar
  4. 4. Mitevska E, Kostovska N, Vasilevska K, Trajkov D. Stereological study of thymus after dexamethasone application. Maced Pharm Bull. 2004; 50(2): 25-28.
    Search in Google Scholar
  5. 5. Mitevska E, Spiroski M. Qualitative histological analysis of adrenal cortex following application of medroxyprogesterone acetate. Maced J Med Sci. 2010; 3(2): 123-131.
    Open DOISearch in Google Scholar
  6. 6. Mitevska E, Spiroski M. Quantitative analysis of adrenal cortical histological alterations after application of medroxyprogesterone acetate. Maced J Med Sci. 2010; 3(4): 352-357.
    Open DOISearch in Google Scholar
  7. 7. Staples LD, Binns RM, Heap RB. Influence of certain steroids on lymphocyte transformation in sheep and goats studied in vitro. J Endocrinol. 1983; 98(1): 55-69.
    Open DOISearch in Google Scholar
  8. 8. Golikov PP, Bobkova AS. Effect of steroid hormones on DNA matrix activity and glucocorticoidreceptor interaction. Probl Endocrinol. 1981; 27(3): 52-6.
    Search in Google Scholar
  9. 9. Maule AG, Schreck CB. Glucocorticoid receptors in leukocytes and gill of juvenile coho salmon (Oncorhynchus kisutch). Gen Comp Endocrinol. 1990; 77(3): 448-55.
    Open DOISearch in Google Scholar
  10. 10. Jeklova E, Leva L, Jaglic Z, Faldyna M. Dexamethasone- induced immunosuppression: a rabbit model. Veterinary Immunology and Immunopathology. 2008; 122(3-4): 231-240.
    Open DOISearch in Google Scholar
  11. 11. Marchetti MC, Di Marco B, Cifone G, Migliorati G, Riccardi C. Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood. 2003; 101(2): 585-93.
    Open DOISearch in Google Scholar
  12. 12. Marchetti MC, Marco BD, Santini MC, Bartoli A, Delfino DV, Riccardi C. Dexamethasone-induced thymocytes apoptosis requires glucocorticoid recaptor nuclear translocation but not mitochondrial membrane potential transition. Toxicology letters. 2003; 139: 175-180.
    Open DOISearch in Google Scholar
  13. 13. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, Riccardi C. Dexamethasone- induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphorinositide- specific phospholipase C, acidic sphingomyelinase, and caspases. Blood. 1999; 93(7): 2282-96.
    Open DOISearch in Google Scholar
  14. 14. Selman PJ, van Garderen E, Mol JA, van den Ingh TS. Comparison of the histological changes in the dog after treatment with the progestins medroxyprogesterone acetate and proligestone. Vet Q. 1995; 17(4): 128-33.
    Open DOISearch in Google Scholar
  15. 15. Kosaka A, Yamashita A. Experimental study of combination medical endocrine therapy on DMBAinduced mammary tumor, with special reference to the effect of drug-dose on various factors. Gan To Kagaku Ryoho. 1992; 19(1): 75-81.
    Search in Google Scholar
  16. 16. Mitevska SE, Gerasimovska AZ, Kakaseva SL, Trajkov KD, Jurhar RM, Stojoska EP, Spiroski ZM. Histophisiology of the spleen after application of medroxyprogesterone acetate. Zbornik matice srpske za prirodne nauke / Proceedings for Natural Sciences, Matica Srpska. 1998; 95: 25-32.
    Search in Google Scholar
  17. 17. Mitevska E, Spiroski M. Histological characteristics of mesenteric lymph nodes after application of medroxyprogesterone acetate. Makedonski medicinski pregled. 1998; 52(1-2): 3-7.
    Search in Google Scholar
  18. 18. Mitevska E. Histological characteristics of thymus assessed with stereological parameters after medroxyprogesterone acetate application. Maced J Med Sci. 2011; 4(4): 367-371.
    Open DOISearch in Google Scholar
  19. 19. Kleynhans L, Du Plessis N, Allie N, Jacobs M, Kidd M, Van Helden P, et al. The Contraceptive Depot Medroxyprogesterone Acetate Impairs Mycobacterial Control and Inhibits Cytokine Secretion in Mice Infected with Mycobacterium tuberculosis. Infect Immun. 2013; 81(4): 1234-1244.
    Open DOISearch in Google Scholar
  20. 20. Baker HJ, Lindsey JR, WeisbrothSH, The Laboratory Rat. Research Applications, Academic Press 1980; USA.
    Search in Google Scholar
  21. 21. Hebel R, Stromberg MW. Anatomy and Embryology of the Laboratory Rat, BioMed Verlag 1986; Germany.
    Search in Google Scholar
  22. 22. Muss HB, Case LD, Atkins JN, Bearden JD 3rd, Cooper MR, Cruz JM, et al. Tamoxifen versus highdose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer. Journal of Clinical Oncology. 1994; 12(8): 1630-1638.
    Open DOISearch in Google Scholar
  23. 23. Pronin VN, Pukhlikov AV. Characteristics of the surgical stage in the combined treatment of poorly differentiated cancer of the corpus uteri. Vopr Oncol. 1988; 34(9): 1102-1105.
    Search in Google Scholar
  24. 24. Senga O, Miyakawa M, Hikita H, Horigome N, Kouzu S, Kuwae K, et al. A case of complete response of breast cancer with pulmonary metastases to combination therapy of 5 DFUR and MPA. Gan To Kagaku Ryoho. 1994; 21(15): 2655-2658.
    Search in Google Scholar
  25. 25. Gudovic R, Matavulj M, Stefanovic N, Lozanov- Cvetkovic Z. Osnovi stereologije. Folia anatomica. 1994; 21/22(2): 13.
    Search in Google Scholar
  26. 26. Kalisnik M Temelji stereologije. Acta Stereologica 1985; 4(1): 1-148.
    Search in Google Scholar
  27. 27. Bianchini R, Nocentini G, Krausz LT, Fettucciari K, Coaccioli S, Ronchetti S, Riccardi C. Modulation of Pro- and Antiapoptotic Molecules in Double-Positive (CD4+CD8+) Thymocytes following Dexamethasone Treatment. JPET. 2006; 319(2): 887-897.
    Open DOISearch in Google Scholar
  28. 28. Catalano G, Altomare D, Laurentaci G. Immunodepressive action and effects of medroxyprogesterone acetate on the lymphatic tissue of the spleen of rabbits. Arch Sci Med. 1982; 139(3): 269-278.
    Search in Google Scholar
  29. 29. Rondinone CM, Schillaci R, Castillo MB, roldan A. Inhibitory effect of 11 β-hydroxypregna-1,4-diene-3,20-dione (delta HOP) on lymphocyte proliferation. Clin Exp Imunol. 1991; 86(2): 311-314.
    Open DOISearch in Google Scholar
  30. 30. Corsini G, Puppo F. Effect of medroxyprogesterone acetate upon PHA, Con A and PWM stimulated lymphocytes and on E-rosette function. J Immunopharmacol. 1982-1983; 4(3):247-253.
    Open DOISearch in Google Scholar
  31. 31. Staples LD, Heap RB, Brown D, Marrs RW. Structural requirements for steroid inhibition of sheep lymphocyte mitogenesis in vitro. Steroids. 1984; 44(5): 419-433.
    Open DOISearch in Google Scholar
  32. 32. Malarkey WB, Burleson Cacioppo JT, Poehlmann K, Glaser R, Kiecolt-Glaser JK. Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women. Endocrine. 1997; 7(2): 227-233.
    Open DOISearch in Google Scholar
  33. 33. Mantovani G, Maccio A, Esu S, Lai P, Santona MC, Massa E, et al. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur J Cancer. 1997; 33(4): 602-607.
    Open DOISearch in Google Scholar
  34. 34. Scambia G, Panici PB, Maccio A, Castelli P, Serri F, Mantovani G, et al. Effects of antiestrogen and progestin on immune functions in breast cancer patients. Cancer. 1988; 61(11): 2214-2218.
    Open DOISearch in Google Scholar
  35. 35. Huber H, Huslein P, Muchalica W, Wagenbichler P. radiosensitising effect of medroxyprogesterone acetate on endometrial cancer cells in vitro. Cancer. 1984; 54: 999-1001.
    Open DOISearch in Google Scholar
  36. 36. Al-Sumidaie AM. The effect of tamoxifen and medroxyprogesterone on giant cell formation by monocytes from patients with breast cancer. J Cancer Res Clin Oncol. 1988; 114(4): 399-404.
    Open DOISearch in Google Scholar
  37. 37. Coldham NG, Lai LC, Ghilchik MW, Walker MM, James VH, Reed MJ. The effect of treatment with 4- hydroxyandrostenedione or medroxyprogesterone acetate on human breast tumour regression. Anticancer Research. 1993; 13(3): 753-758.
    Search in Google Scholar
  38. 38. King KL, Cidlovski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol. 1998; 60: 601-617.
    Open DOISearch in Google Scholar
  39. 39. Zieger G, Zieger W, Kubatsch B. Effect and duration of gestagen influence on adrenal cortex and ovary. A morphological study in the Syrian golden hamster. Pathol Res Pract. 1982; 173(3): 202-217.
    Open DOISearch in Google Scholar
  40. 40. Vicent GP, Pecci A, Ghini AA, Piwien-Pilipuk G, Valeiro AS, Burton G, et al. The glucocorticoid properties of the synthetic steroid pregna-1,4-diene-11beta-ol-3,20-dione (delta-HOP) are not entirely correlated with the steroid binding to the glucocorticoid receptor. Mol Cell Endocrinol. 1999; 149(1-2): 207-219.
    Open DOISearch in Google Scholar
  41. 41. Henson PM, Bratton DL. Antiinflamatory effects of apoptotic cells. J Clin Invest. 2013; 123(7): 2773-2774.
    Open DOISearch in Google Scholar
  42. 42. Freire-de-Lima CG, Yi Qun Xiao, Gardai SJ, Bratton DL, Schiemann WP, Henson PM. Apoptotic cells, through transforming growth factor-β, co-ordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages. Journal of Biological Chemistry. 2006; 281: 38376-38384.
    Open DOISearch in Google Scholar
  43. 43. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. JEM. 1998; 188(5): 887.
    Open DOISearch in Google Scholar
  44. 44. Beijerink NJ, Bhatti SFM, Okkens AC, et al. Adenohypophiseal function in bitches treated with medroxyprogesterone acetate. Dom Anim Endocrinol. 2007; 32: 63-78.
    Open DOISearch in Google Scholar
  45. 45. Kleynhans L, Du Plessis N, Black GF, Loxton AG, Kidd M, Van Helden PD, et al. Medroxyprogesterone Acetate Alters Mycobacterium Bovis BCGInduced Cytokine Production in Peripheral Blood Mononuclear Cells of Contraceptive Users. PLoS One 2011; 6(9): e24639. doi:10.1371/journal.pone.0024639.
    Open DOISearch in Google Scholar
  46. 46. Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW Mice. Arthritis & Rheumatism. 2009; 60(6): 1775-1784.
    Open DOISearch in Google Scholar
  47. 47. Selman PJ, Mol JA, Rutteman GR, Rijnberk A. Progestin treatment in the dog. II. Effects on the hypothalamic-pituitary-adrenocortical axis. European Journal of Endocrinology. 1994; 131(4): 422-430.
    Open DOISearch in Google Scholar
  48. 48. Fenton SL, Luong QT, Sarafeim A, Mustard KJ, Pound J, Desmond JC, et al. Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt’s lymphoma cells and cell lines: potential for applying old drugs to a new disease. Leukemia. 2003; 17(3): 568-575.
    Open DOISearch in Google Scholar
  49. 49. Tomasicchio M, Avenant C, Du Toit A, Ray RM, Hapgood JP. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. PLoS One 2013; 8(5):e62895. doi: 10.1371/journal pone.0062895.
    Search in Google Scholar
  50. 50. Bakry S, Ahmed HA, Al-OtaibiPrenatal ML. Exposure to medroxyprogesterone acetate. American- Eurasian Journal of Toxicological Sciences. 2010; 2(1): 01-12.
    Search in Google Scholar
  51. 51. Vermeulen M, Pazos P, Lanari C, Molinolo A, Gamberale R, Geffner JR, Giordano M. Medroxypro gesterone acetate enhances in vivo and in vitro antibody production. Immunology. 2001; 104(1): 80-86.
    Open DOISearch in Google Scholar
  52. 52. Ory K, Lebeau J, Levalous C, Bishay, Fouchet P, Allemand I, et al. Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines. Breast cancer Res Treat. 2001; 68(3): 187-198.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/prilozi-2015-0074 | Journal eISSN: 1857-8985 (formerly 0350-1914) | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 13 - 25
Published on: Apr 14, 2016
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
spleen,
Wistar rats,
stereological analysis,
dexamethasone and medroxyprogesterone acetate
Related subjects:
Social sciences,
Education,
Education, other

© 2016 Elida Mitevska, Irena Kostadinova-Petrova, Nevena Kostovska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 36 (2015): Issue 3 (December 2015)
Previous article
Next article